Megatrend · Synthetic Biology

The dream that deflated, and the survivor hiding in a fermentation tank

A few years ago, "plant-based meat" was hyped as the thing that would change the world and help save the climate. Then the bubble burst — stocks fell 90%+ and companies collapsed one after another. The more interesting story is what survived and is quietly growing — not the burgers in the supermarket, but the protein "fermented" inside a tank.

Category Synthetic Biology (non-pharma) Level Sub-theme Maturity Emerging Read time ~12 min
A large fermentation tank producing milk protein like a cow, with the silhouette of a cow gradually turning into a fermentation tank, microbes at work inside.
ภาพประกอบ (hero.png)
Fermenting animal protein, with no animal. The heart of the new era is in the tank, not on the farm.

01What it is

Raising animals for meat and milk is one of the most resource-hungry activities on the planet — it uses enormous amounts of land and water, and emits roughly 15% of the world's greenhouse gases. The question that lit up this whole industry is: can we get the same old protein without raising animals?

There are three main approaches, and it's crucial to tell them apart — because their fates are wildly different:

  • Plant-based: take pea or plant protein and engineer it to imitate the taste and texture of meat, like Beyond Meat — the easiest to make, but still just a "copy"
  • Precision fermentation: use genetically engineered microbes to "ferment" animal protein (like the whey protein in milk) that is identical at the molecular level — this is the real hero of the lesson
  • Cultivated meat: grow real animal cells in a tank, getting real meat without killing an animal — the most cutting-edge, but still expensive and tangled in regulation
Key terms
Precision Fermentation

A technique that uses microbes (like genetically engineered yeast) as "tiny factories" to make a specific protein or compound — similar to brewing beer, except instead of producing alcohol, the yeast is programmed to make whey, casein, or egg white. The result is protein that's "exactly like the animal version" but with no animal involved at all (the same technique that's been used to make insulin for decades).

On the megatrend map, this node sits under Synthetic Biology (non-pharma) — it's taking the tools of synthetic biology and applying them to "food" instead of medicine.

02The dream, and the bubble that burst

Around 2019–2021, this trend ran red-hot. Beyond Meat went public and its stock shot through the ceiling; investors believed "plant-based meat" would take a slice of global meat consumption. Then reality arrived — it cost more than real meat, the taste was "almost but not quite," the "ultra-processed" backlash made people question the health angle, and once the novelty faded, sales dove.

A burger-shaped balloon deflating on a pedestal under a spotlight, signaling a once-hyped trend that fizzled, with a small green sprout growing beside it.
ภาพประกอบ (crash.png)
The air going out of the bubble. A trend that was over-hyped slowly deflates — but something more durable survived.

Beyond Meat's numbers tell the story clearly. Q1 2025 sales were $68.7 million (down 9% year over year), and worse, its gross margin was negative — the more it sold, the more it lost. The stock fell over 90% from its peak, the company had to restructure heavily, and it pulled out of China.

−90%+ the fall in Beyond Meat's stock from its peak — a symbol of the alt-protein bubble bursting in 2022–2025

But this isn't the end of the story. It's a "shakeout" instead — because beneath the wreckage of the plant-based-meat trend, the overall alternative-protein market is still growing — it's just that money and hope are moving from "burger brands" to "the technology behind them."

The global alternative-protein market
market value ($ billions) — 2030–2035 are projections
Source: Future Market Insights (CAGR ~14%); plant-based still holds ~62% of the share, but is being challenged by the fermentation side

03How it works (fermenting protein)

The key that sets precision fermentation completely apart from plant-based meat is one phrase: "exactly the same," not "imitation." Plant-based meat tries to fool your tongue with pea protein, but precision fermentation produces protein from the same molecule as the one in real milk or eggs.

Cow vs. fermentation A cow and a microbial fermentation tank make the same molecule of whey protein, but the tank uses far fewer resources Old way · raise a cow uses a lot of land · water · time whey protein New way · ferment with microbes uses far fewer resources the same whey = the exact same protein molecule (unlike plant-based meat, which only imitates)
Different paths, same destination. Both the cow and the fermentation tank make the "same" whey protein — but the tank uses far less land, water, and time.

Because it's the same protein, it behaves in food exactly like the real thing — it dissolves, foams, makes cheese, and delivers the same nutrition. Unlike pea protein, which usually shifts the taste and texture. That's why many see precision fermentation as the "right path" for alt-protein. The challenge is cost and scale — fermenting in large industrial-scale tanks is still expensive, and capacity is still limited.

04How it connects in the ecosystem

This node sits at an interesting intersection of several megatrends:

  • Replaces land and resources: fermenting in a tank uses far less space and water than raising animals, making it an option that eases the pressure on the planet's resources
  • Helps climate goals: livestock emits about 15% of the world's greenhouse gases, so fermented protein is seen as a decarbonization tool for the food system
  • Leans on AI: "designing the microbial strain" to produce the target protein better and cheaper relies more and more on AI and computational biology
  • Deeply tied to Biotech: it's built on the same fermentation technology used to manufacture biologic drugs — a company good at tank fermentation can play in both the drug and food worlds
A perspective — the unexpected connection The hottest connection right now actually comes from the GLP-1 drugs (weight-loss drugs like Ozempic) — people on these drugs eat less but need higher "protein per bite" to preserve muscle mass, which is sending demand for high-quality protein soaring. It's a classic example of one megatrend (drugs) lighting a fire under another (protein) in a way no one saw coming.

05Where it stands now

The picture today splits clearly into two worlds. On one side, plant-based meat is still slumping, while on the other, precision fermentation is taking off — especially in the "sell ingredients to big brands (B2B)" model, not selling to consumers directly.

The clearest example is Perfect Day, which already has its fermented whey protein approved in the U.S. and has teamed up with food giants like Mars, Unilever, and General Mills (over $115 billion in combined revenue) to put fermented protein into their products — a smart "picks and shovels" strategy: no need to fight brand-to-brand on the shelf, just be the "ingredient behind the scenes" of every brand.

A central ingredient silo dispensing protein powder out to several different brand products around it, signaling a strategy of selling ingredients rather than brands.
ภาพประกอบ (b2b.png)
Sell the ingredient, not the brand. The real winner is the one behind every brand, not the brand on the shelf.

The precision-fermentation side itself has a very high growth rate (but off a small base, so read it carefully). The overall precision-fermentation market is estimated to grow from about $5.8 billion in 2025 to the hundred-billion-dollar range by the early 2030s, at a CAGR above 40%.

The Precision Fermentation market (the path that's coming)
market value ($ billions) — small base, fast growth, high uncertainty
Source: Custom Market Insights, GM Insights (CAGR ~43% — a figure off a small base, best read as a direction rather than a precise number)

And don't forget the new tailwind from GLP-1 drugs, which are changing how a whole country eats. About 23% of U.S. households now use this class of drug, and nearly half of consumers worldwide plan to eat more protein.

The protein demand wave from the GLP-1 era
consumption signals (approximate %)
Source: Nutrition Insight, Novonesis, ADM (estimates)
Key players in this field
Note
This list focuses on the leaders in precision fermentation and B2B ingredients, plus the global amino-acid fermentation leaders in Asia that form the core of the fermentation/ingredient theme — only the players at the heart of the trend, not just any big food company.
NovonesisNSIS · DK
Denmark · ingredient giant
Formed from the merger of Novozymes + Chr. Hansen — the world leader in enzymes and fermentation, a true "picks and shovels" play that benefits from both alt-protein and the GLP-1 wave.
core · the winner behind the scenes
ADMADM · US
United States
A food-ingredient giant, the B2B partner of Perfect Day, with protein solutions for GLP-1 users — selling to every brand, never competing on the shelf.
core · B2B ingredients
dsm-firmenichDSFIR · NL
Netherlands/Switzerland
A nutrition and fermentation giant backing the startup Vivici, which just launched a fermented milk protein (Vivitein BLG) in the U.S. in 2025.
core · fermentation + nutrition
Kerry GroupKRZ · IE
Ireland
A flavor and ingredient giant, another "back kitchen" of the food industry that benefits from the alternative-protein trend.
core · ingredients
Beyond MeatBYND · US
United States
The symbol of the plant-based-meat bubble — an expensive lesson in how fragile a "consumer brand" is in this arena (negative gross margin, stock −90%+).
secondary · the lesson
OatlyOTLY · SE
Sweden
The oat-milk brand that was once a rising star, but ran into profit pressure and competition all the same — a reflection of how hard it is to be a "brand" in this market.
secondary · consumer brand
IFFIFF · US
United States · ~$18B
A flavors & fragrances giant with a Health & Biosciences division (enzymes, microbes, fermentation, from the DuPont N&B merger) — another "picks and shovels" play that supplies the ingredients behind the food industry.
core · fermentation leader
CJ CheilJedang097950 · KR
South Korea
Owner of CJ BIO, the world leader in fermented amino acids (lysine/tryptophan, #1 share, supplying 37+ countries), and developing fermented ingredients for plant-based food lines — true fermentation-at-scale.
core · global-scale fermentation
MeiHua Holdings600873 · CN
China · ~$4B
One of the world's largest makers of fermented amino acids (MSG, threonine, lysine) — a clear example of the "economics of industrial-scale fermentation," where big scale pushes unit costs down.
core · giant-scale fermentation
SunOptaSTKL · US
United States
A B2B plant-based ingredient maker (oat/soy bases) supplying many plant-milk brands — the "back office" of the alternative-milk shelf.
core · B2B plant-based

06The road ahead

The first direction is "cost parity" — the big goal of precision fermentation is to make fermented protein cost the same as, or less than, animal protein, which many see as drawing near for some products. Once it hits that point, it's no longer a "premium for the environment" — it becomes a genuinely worthwhile choice.

A plate where the sugar portion shrinks and fades while the high-protein portion is pushed forward and emphasized, signaling that GLP-1 drugs are changing how people eat.
ภาพประกอบ (glp1.png)
The plate of the new era. GLP-1 drugs are turning "protein per bite" into what consumers go looking for.

The second direction is expanding from "milk" into other kinds of protein. The same fermentation technique can produce egg white, collagen, or specialized proteins, turning it into a "platform" rather than a single product — whoever controls the technology and the fermentation capacity can play in several markets at once.

The third direction is that the "ingredient behind the scenes" model will increasingly beat the "brand" model. The lesson from Beyond Meat taught the whole industry that supplying ingredients to food giants that already have distribution is safer and more sustainably profitable than building a competing brand of your own.

07Challenges & risks

Even though the technology story is exciting, the risks are real — and were just proven, freshly and painfully.

The first risk is the "graveyard of consumer brands" — the lessons of Beyond Meat and Oatly make it clear that being a direct-to-consumer brand in this market is brutal: high costs, fierce competition, and consumer tastes that shift fast. Investors who get pulled into chasing a "cool brand" usually get hurt badly.

The second risk is cost and scale. Industrial-scale tank fermentation is still expensive, and building fermentation capacity takes heavy investment. If costs don't fall to where they can compete with the real thing, the market will grow slower than the dream — and that pretty 40%+ CAGR comes off a very small base, so read it carefully.

The third risk is acceptance and regulation. Some consumers are still uneasy about "lab-made food" and "ultra-processed" products, and there's a fight over labeling too — can you call fermented protein "milk," or cultivated meat "meat"? That's a point the legacy livestock industry is fighting hard.

The bottom line for investors Alt-Protein is a trend where "the direction is right, but the timing and who wins are everything" — the first round taught us: don't bet on the hot consumer brand. Instead, look for "picks and shovels": the companies that sell the enzymes, fermentation, and ingredients to every brand (like the ingredient giants), which profit no matter who wins on the shelf — plus the new tailwind from GLP-1. The real value is in the technology and ingredients behind the scenes, not the logo on the box.

In short: Alt-Protein is the story of a dream that got too big, followed by a painful shakeout, and the discovery that the real survivor is quieter and in the back — inside the fermentation tank and the ingredient supply chain, not on the billboard. Understanding this difference is understanding why a trend where "the stock fell 90%" is still one of the most worth-watching trends of the era.

Explore this theme — live data, stocks & news →